ADCT
HEALTHCAREAdc Therapeutics SA
$3.86+0.10 (+2.66%)PRE
Live · NYSE · May 9, Close
AI Insight
What's Moving ADCT Today?
No stock-specific AI insight has been generated for ADCT yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.25$4.98
$3.86
Fundamentals
Market Cap$491M
P/E Ratio—
EPS$-0.97
Dividend Yield—
Dividend / Share—
ROE-7.1%
Profit Margin-1.7%
Debt / Equity—
Trading
Volume2.6M
Avg Volume (10D)—
Shares Outstanding127.2M
ADCT News
20 articles- ADC Therapeutics (ADCT) Q4 2025 Earnings Call TranscriptMotley Fool·May 4, 2026
- ADC Therapeutics S.A. Q1 2026 Earnings Call SummaryMoby·May 4, 2026
- ADCT Q1 2026 Earnings Call TranscriptMotley Fool·May 4, 2026
- ADC Therapeutics Q1 Earnings Call HighlightsMarketbeat·May 4, 2026
- ADC Therapeutics SA (ADCT) Reports Q1 Loss, Beats Revenue EstimatesYahoo Finance·May 4, 2026
- ADC Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational UpdatesYahoo Finance·May 4, 2026
- Are Medical Stocks Lagging ADC Therapeutics (ADCT) This Year?Yahoo Finance·May 1, 2026
- ADC Therapeutics Makes Grants to New Employees Under Inducement PlanYahoo Finance·May 1, 2026
- ADC Therapeutics to Host First Quarter 2026 Financial Results Conference Call on May 4, 2026Yahoo Finance·Apr 27, 2026
- Is ADC Therapeutics (ADCT) Stock Outpacing Its Medical Peers This Year?Yahoo Finance·Apr 15, 2026
- ADC Therapeutics Announces New Employee Inducement GrantYahoo Finance·Apr 1, 2026
- Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year?Yahoo Finance·Mar 30, 2026
- ADC Therapeutics Eyes ZYNLONTA Expansion as LOTIS-5 Data Nears at H.C. Wainwright ChatMarketbeat·Mar 27, 2026
- ADC Therapeutics (ADCT) Reports 2025 Revenue of $73.6M With Cash Runway Into 2028Yahoo Finance·Mar 18, 2026
- Is ADC Therapeutics (ADCT) Outperforming Other Medical Stocks This Year?Yahoo Finance·Mar 13, 2026
- ADC Therapeutics SA (ADCT) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic ...Yahoo Finance·Mar 10, 2026
- ADC Therapeutics Q4 Earnings Call HighlightsMarketbeat·Mar 10, 2026
- ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue EstimatesYahoo Finance·Mar 10, 2026
- ADC Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Operational UpdateYahoo Finance·Mar 10, 2026
- ADC Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 10, 2026Yahoo Finance·Mar 3, 2026
All 20 articles loaded
Price Data
Open$3.73
Previous Close$3.76
Day High$3.87
Day Low$3.60
52 Week High$4.98
52 Week Low$1.25
52-Week Range
$1.25$4.98
$3.86
Fundamentals
Market Cap$491M
P/E Ratio—
EPS$-0.97
Dividend Yield—
Dividend / Share—
ROE-7.1%
Profit Margin-1.7%
Debt / Equity—
Trading
Volume2.6M
Avg Volume (10D)—
Shares Outstanding127.2M
About Adc Therapeutics SA
ADC Therapeutics SA, a biotechnology company focused on clinical stage oncology, develops Antibody Drug Conjugates (ADC) for patients suffering from hematologic malignancies and solid tumors. The company is headquartered in Epalinges, Switzerland.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNYSE
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—